Vertex Pharmaceuticals
VRTX
VRTX
1,672 hedge funds and large institutions have $104B invested in Vertex Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 150 funds opening new positions, 675 increasing their positions, 588 reducing their positions, and 104 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
1% more funds holding
Funds holding: 1,661 → 1,672 (+11)
3% less capital invested
Capital invested by funds: $107B → $104B (-$3.33B)
1.63% less ownership
Funds ownership: 92.99% → 91.36% (-1.6%)
Holders
1,672
Holding in Top 10
17
Calls
$851M
Puts
$684M
Top Buyers
| 1 | +$1.78B | |
| 2 | +$463M | |
| 3 | +$310M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$190M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$183M |
Top Sellers
| 1 | -$685M | |
| 2 | -$405M | |
| 3 | -$284M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$273M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$242M |
